Company Profile

Metabolix Inc
Profile last edited on: 10/9/21      CAGE: 1TLJ3      UEI: MPBJJLNZKV29

Business Identifier: Sustainable, clean solutions for plastics, fuels and chemicals, plastics and chemicals industries
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

21 Erie Street
Cambridge, MA 02139
   (617) 583-1700
Location: Multiple
Congr. District: 07
County: Middlesex

Public Profile

Metabolix Inc is focused on providing sustainable solutions in order to meet the world's needs for plastics, chemicals and energy. Metabolix is developing commercially viable chemicals from biobased sources as opposed to fossil fuels, which produce the vast majority of chemicals today. Today, four carbon (C4) chemicals are produced from non-renewable, fossil-based hydrocarbons and are used to make spandex fibers, polyurethanes, engineering resins, and personal care products. The company is integrating biotechnology with advanced industrial practices in order to develop and commercialize a family of high-performance PHA biopolymers that are targeted to the film and bag applications, performance additives and functional biodegradation markets. These polymers, called Mirel bioplastics, are a sustainable and biodegradable alternative to petroleum based plastics. Mirel is suitable for injection molding, cast and blown film, sheet, extrusion coating, and thermoforming. Metabolix is also developing a proprietary platform technology for co-producing plastics, chemicals and energy from crops such as switchgrass, oilseeds and sugarcane.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2009 2 USDA $429,421
Project Title: Blow Molded Bioproducts from Renewable Plastics
1996 1 NIH $99,799
Project Title: PHO Biopolymer For Controlled Release
1994 1 NIH $81,000
Project Title: Novel Biopolymers for the Medical Industry
1993 1 AF $70,000
Project Title: Biodegradable Plastic Media Blast Materials
1993 1 NIH $50,000
Project Title: Catalytic antibodies for therapeutic applications

Key People / Management

  Thomas Auchincloss -- Head of Business Development - New Technologies

  James J Barber -- Former President

  Lynne H Brum -- Vice President, Marketing & Corporate Communications

  Robert Engle -- Vice President Business/Commercial Development & Biopolymers

  Richard P Eno -- Former President

  Joseph Hill -- Chief Financial Officer

  Jay Kouba -- former President

  Raj Krishnaswamy -- Senior Scientist

  Ben Locke -- Director of Government Programs

  Oliver P Peoples -- Chief Scientific Officer

  Max Senechal -- Vice President, Strategy & Commercial Developement

  Anthony J Sinskey -- Founder

  Robert L Van Nostrand -- Chairman and Director

  Johan Van Walsem -- Chief Operating Officer

  Johan van Walsem -- COO